Episode

How Turbine Accelerates Drug Discovery with AI Simulation | Szabi Nagy, CEO and Co-Founder of Turbine

Podcast
Nucleate Podcast
Published
Feb 24, 2026
Duration seconds
3400
Processing state
not_requested
Canonical source
https://nucleate-signal.simplecast.com/episodes/founders-lessons-in-building-impact-beyond-the-lab-szabi-nagy-ceo-and-co-founder-of-turbine-wF_lLnS9
Audio
https://cdn.simplecast.com/media/audio/transcoded/a2677e57-b5ce-490f-93be-59631c3a5218/6a0defb6-ad56-4c08-b015-fea36f1c159f/episodes/audio/group/47418101-75ab-4859-926a-dd7871c78db6/group-item/c3ed866b-9967-4ad0-9a22-7fb88b7e3a65/128_default_tc.mp3?aid=rss_feed&feed=OdcQl6Pu
JSON
/v1/public/podcasts/nucleate-podcast-6322042/episodes/how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine
Markdown
/podcast/nucleate-podcast-6322042/how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/nucleate-podcast-6322042/how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode we are joined by Szabi Nagy, CEO and Co-Founder of Turbine. He shares his first startup experience, and how the lessons he learned there helped shape his work at Turbine. He then goes on to introduce the company’s virtual lab platform, which allows researchers to simulate experiments with AI and accelerate drug discovery. Throughout the discussion, Szabi provides honest insights into fundraising in today’s tight capital markets and offers valuable advice for biotech founders on how to stay resilient while navigating uncertainty and building impactful companies.